Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to evaluate the possible crosstalk between GM dysbiosis and vitamin D deficiency in the pathogenesis of HTN.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production

Study design awaiting verification · Clinical Cardiology · 2019

Original publication title

Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production

Kun Zuo; Jing Li; Qiuhua Xu; Chaowei Hu; Yuanfeng Gao; Mulei Chen; Roumu Hu; Ye Liu; Hongjie Chi; Qing Yin; Yudan Cao; Pan Wang; Yanwen Qin; Xiaoyan Liu; Jiuchang Zhong; Jun Cai; Kuibao Li; Xinchun Yang

© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our findings suggest that the GM dysbiosis contributing to the development of HTN might be partially mediated by vitamin D3 deficiency. Future studies involving the underlying mechanism and intervention strategies targeting microbiome composition and vitamin D3 to counteract the progression of HTN are warranted.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Accumulating studies have suggested that gut microbiota (GM) dysbiosis and vitamin D3 deficiency each play an important role during the progression of hypertension (HTN). However, few studies have characterized the underlying interaction between GM shift and vitamin D3 deficiency in HTN patients.

Source: Background

Abstract: What methods does the paper describe?

In a cohort of 34 HTN patients and 15 healthy controls, we analyzed the fecal microbiota products, GM composition, and the interaction between GM and vitamin D3.

Source: Methods

Abstract: Hypothesis

This study aimed to evaluate the possible crosstalk between GM dysbiosis and vitamin D deficiency in the pathogenesis of HTN.

Source: Hypothesis

Abstract: Results

Vitamin D3 was significantly decreased in feces of HTN patients (P = .006, vs controls) and was correlated with altered GM, including decreased Shannon index (R 2 = 0.1296, P = .0111) and Pielou evenness (R 2 = 0.1509, P = .0058). Moreover, vitamin D3 positively correlated with HTN‐reduced bacterial genera, including Subdoligranulum (R 2 = 0.181, P = .0023), Ruminiclostridium (R 2 = 0.1217, P = .014), Intestinimonas (R 2 = 0.2036, P = .0011), Pseudoflavonifractor (R 2 = 0.1014, P = .0257), Paenibacillus (R 2 = 0.089, P = .0373), and Marvinbryantia (R 2 = 0.08173, P = .0464).

Partial least squares structural equation modeling showed that 27.7% of the total effect of gut microbiome on HTN was mediated by limiting vitamin D production. Finally, receiver operating characteristic curve analysis revealed the predictive capacity of differential gut microbiome signatures and decreased vitamin D3 to distinguish HTN patients (AUC = 0.749, P = .006).

Source: Results

Abstract: Conclusions

Our findings suggest that the GM dysbiosis contributing to the development of HTN might be partially mediated by vitamin D3 deficiency. Future studies involving the underlying mechanism and intervention strategies targeting microbiome composition and vitamin D3 to counteract the progression of HTN are warranted.

Source: Conclusions
Authors’ abstract

Abstract

Background

Accumulating studies have suggested that gut microbiota (GM) dysbiosis and vitamin D3 deficiency each play an important role during the progression of hypertension (HTN). However, few studies have characterized the underlying interaction between GM shift and vitamin D3 deficiency in HTN patients.

Hypothesis

This study aimed to evaluate the possible crosstalk between GM dysbiosis and vitamin D deficiency in the pathogenesis of HTN.

Methods

In a cohort of 34 HTN patients and 15 healthy controls, we analyzed the fecal microbiota products, GM composition, and the interaction between GM and vitamin D3.

Results

Vitamin D3 was significantly decreased in feces of HTN patients (P = .006, vs controls) and was correlated with altered GM, including decreased Shannon index (R 2 = 0.1296, P = .0111) and Pielou evenness (R 2 = 0.1509, P = .0058). Moreover, vitamin D3 positively correlated with HTN‐reduced bacterial genera, including Subdoligranulum (R 2 = 0.181, P = .0023), Ruminiclostridium (R 2 = 0.1217, P = .014), Intestinimonas (R 2 = 0.2036, P = .0011), Pseudoflavonifractor (R 2 = 0.1014, P = .0257), Paenibacillus (R 2 = 0.089, P = .0373), and Marvinbryantia (R 2 = 0.08173, P = .0464).

Partial least squares structural equation modeling showed that 27.7% of the total effect of gut microbiome on HTN was mediated by limiting vitamin D production. Finally, receiver operating characteristic curve analysis revealed the predictive capacity of differential gut microbiome signatures and decreased vitamin D3 to distinguish HTN patients (AUC = 0.749, P = .006).

Conclusions

Our findings suggest that the GM dysbiosis contributing to the development of HTN might be partially mediated by vitamin D3 deficiency. Future studies involving the underlying mechanism and intervention strategies targeting microbiome composition and vitamin D3 to counteract the progression of HTN are warranted.

Publication and source details

Original title: Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production

Kun Zuo; Jing Li; Qiuhua Xu; Chaowei Hu; Yuanfeng Gao; Mulei Chen; Roumu Hu; Ye Liu; Hongjie Chi; Qing Yin; Yudan Cao; Pan Wang; Yanwen Qin; Xiaoyan Liu; Jiuchang Zhong; Jun Cai; Kuibao Li; Xinchun Yang

Clinical Cardiology · 2019

* Correspondence
Xinchun Yang, MD, PhD, Heart Center, Beijing ChaoYang Hospital, Capital Medical University, Beijing Key Laboratory of Hypertension, 8th Gongtinanlu Road, Chaoyang District, Beijing 100020, China.
Email: yxc6229@163.com
Kuibao Li, MD, PhD, Heart Center, Beijing ChaoYang Hospital, Capital Medical University, Beijing Key Laboratory of Hypertension, 8th Gongtinanlu Road, Chaoyang District, Beijing 100020, China.
Email: kuibaoli@126.com
†

Kun Zuo and Jing Li contributed equally to this study.

© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.1351 personnel training planCYMY‐2017‐03Beijing Municipal Administration of Hospitals’ Youth ProgrammeQML20170303Beijing Natural Science Foundation7172080National Natural Science Foundation of China 813703628150038381670214817702538187030881700295

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:41:59.554390+00:00

DOI: 10.1002/clc.23195 · PMC6672427